rs180177102
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(-;-) | 7 | Fanconi anemia, complementation group N |
(-;T) | 5 | PALB2-related cancer risk |
(-;TT) | 5 | PALB2-related cancer risk |
(T;T) | 0 | common in clinvar |
Reference | GRCh38 38.1/141 |
Chromosome | 16 |
Position | 23634954 |
Gene | PALB2 |
is a | snp |
is | mentioned by |
dbSNP | rs180177102 |
dbSNP (classic) | rs180177102 |
ClinGen | rs180177102 |
ebi | rs180177102 |
HLI | rs180177102 |
Exac | rs180177102 |
Gnomad | rs180177102 |
Varsome | rs180177102 |
LitVar | rs180177102 |
Map | rs180177102 |
PheGenI | rs180177102 |
Biobank | rs180177102 |
1000 genomes | rs180177102 |
hgdp | rs180177102 |
ensembl | rs180177102 |
geneview | rs180177102 |
scholar | rs180177102 |
rs180177102 | |
pharmgkb | rs180177102 |
gwascentral | rs180177102 |
openSNP | rs180177102 |
23andMe | rs180177102 |
SNPshot | rs180177102 |
SNPdbe | rs180177102 |
MSV3d | rs180177102 |
GWAS Ctlg | rs180177102 |
Max Magnitude | 7 |
rs180177102, also known as c.1592delT and p.Leu531Cysfs, is a mutation in the PALB2 gene on chromosome 16.
The deletion variant, rs180177102(-), has been found in a 2015 meta-analysis to lead to a combined increased relative risk for breast cancer of 5.3 (CI: 3.0 to 9.4).[PMID 26250988]
A 2016 publication study involving 42,000 breast cancer cases concluded that rs180177102(-) carriers had an odds ratio of 3.44 (CI:1.4-8.5; p=7.1×10e-5) and a 40% (CI: 18-77%) chance of developing the disease by age 70.10.1136/jmedgenet-2016-103839
This mutation appears to be renamed i4000488 by 23andMe.
ClinVar | |
---|---|
Risk | Rs180177102(-;-) |
Alt | Rs180177102(-;-) |
Reference | Rs180177102(T;T) |
Significance | Other |
Disease | Breast cancer Familial cancer of breast Hereditary cancer-predisposing syndrome not provided |
Variation | info |
Gene | PALB2 |
CLNDBN | Breast cancer, susceptibility to Familial cancer of breast Hereditary cancer-predisposing syndrome not provided |
Reversed | 1 |
HGVS | NC_000016.9:g.23646275delA |
CLNSRC | OMIM Allelic Variant PALB2 database |
CLNACC | RCV000001310.2, RCV000114482.2, RCV000132474.5, RCV000212797.2, |
[PMID 17287723] A recurrent mutation in PALB2 in Finnish cancer families.
[PMID 18628482] Penetrance analysis of the PALB2 c.1592delT founder mutation.
[PMID 19383810] The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.